checkAd

     146  0 Kommentare Iterum Therapeutics plc Announces Result of Proposal 8 at Annual General Meeting - Seite 3

    For further information:

    Lesen Sie auch

    CONTACT:
    Investor Contact:
    Judy Matthews
    Chief Financial Officer
    312-778-6073
    IR@iterumtx.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Iterum Therapeutics plc Announces Result of Proposal 8 at Annual General Meeting - Seite 3 DUBLIN, Ireland and CHICAGO, June 15, 2020 (GLOBE NEWSWIRE) - Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, today announced results of its Annual …